Free Trial

Anebulo Pharmaceuticals (ANEB) SEC Filings & 10K Form

Anebulo Pharmaceuticals logo
$1.31 +0.01 (+0.77%)
(As of 12/17/2024 ET)

Recent Anebulo Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/10/2024
8:00 AM
Anebulo Pharmaceuticals (Issuer)
Cunningham, Richard Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:30 PM
Anebulo Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:15 PM
Anebulo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
6:00 AM
Anebulo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:30 PM
Anebulo Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/25/2024
3:15 PM
Anebulo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2024
6:05 AM
Anebulo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
3:23 PM
Anebulo Pharmaceuticals (Issuer)
Aryeh Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:23 PM
Anebulo Pharmaceuticals (Issuer)
SHAH BIMAL R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:23 PM
Anebulo Pharmaceuticals (Issuer)
English Aron R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:23 PM
Anebulo Pharmaceuticals (Issuer)
Lawler Joseph F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:23 PM
Anebulo Pharmaceuticals (Issuer)
Kupchyk Areta (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:23 PM
Anebulo Pharmaceuticals (Issuer)
Calloway Nathaniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:23 PM
Anebulo Pharmaceuticals (Issuer)
Lin Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
7:07 AM
Anebulo Pharmaceuticals (Issuer)
Cundy Kenneth C (Reporting)
Form 4/A
03/01/2024
5:24 PM
Anebulo Pharmaceuticals (Issuer)
Cundy Kenneth C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:22 PM
22NW Fund, LP (Reporting)
22NW, LP (Reporting)
Anebulo Pharmaceuticals (Issuer)
English Aron R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ANEB) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners